3'-o-(4-benzoyl)benzoyladenosine 5'-triphosphate has been researched along with Disease Models, Animal in 26 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (11.54) | 29.6817 |
| 2010's | 21 (80.77) | 24.3611 |
| 2020's | 2 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Bendotti, C; Bonetto, V; D'Agostino, J; Fabbrizio, P; Margotta, C; Mella, G; Nardo, G; Panini, N; Pasetto, L; Raggi, F; Sammali, E; Sorarù, G | 1 |
| Bisti, S; Maggi, MA; Picco, C | 1 |
| Beker, M; Beker, MC; Caglayan, AB; Caglayan, B; Kelestemur, T; Kilic, E; Kilic, U; Ozturk, G; Sahin, F; Sertel, E; Yalcin, E | 1 |
| Cheng, X; Dong, L; Hu, Y; Zhou, L | 1 |
| Al-Khalidi, R; Ambati, J; Ambati, K; Arkle, S; Bruno, C; Chira, N; Cox, P; Gazzerro, E; Górecki, DC; McGeehan, RE; Panicucci, C; Róg, J; Young, CNJ; Zabłocki, K | 1 |
| Agar, E; Arslan, G; Avci, B; Ayyildiz, M; Kocacan, SE; Rzayev, E | 1 |
| Cano, E; del Carmen Serrano-Perez, M; Neria, F; Tranque, P; Urso, K; Velasco, P | 1 |
| Chen, S; Hu, Q; Krafft, PR; Ma, Q; Rolland, W; Sherchan, P; Tang, J; Zhang, J; Zhang, JH | 1 |
| Aluisio, L; Ao, H; Bhattacharya, A; Bonaventure, P; Fraser, I; Letavic, MA; Lord, B; Lovenberg, TW; Neff, RA; Nepomuceno, D; Shoblock, JR; Wang, Q; Welty, N; Wickenden, AD | 1 |
| Hagg, T; Kang, SS; Keasey, MP | 1 |
| de Oliveira-Fusaro, MC; Parada, CA; Tambeli, CH; Teixeira, JM | 1 |
| Antonioli, L; Blandizzi, C; Caputi, V; Colucci, R; Fornai, M; Giron, MC; Orso, G; Pellegrini, C; Sacco, D; Scarpignato, C; Tuccori, M | 1 |
| Chen, Q; Hu, J; Liu, C; Qin, S; Wu, H; Xu, C; Zhang, D | 1 |
| Alves, M; Arribas-Blázquez, M; Artalejo, AR; Bhattacharya, A; Conroy, RM; Delanty, N; Diaz-Hernandez, M; Engel, T; Farrell, MA; Henshall, DC; Jimenez-Pacheco, A; Letavic, M; Miras-Portugal, MT; O'Brien, DF; Olivos-Oré, LA; Sanz-Rodriguez, A | 1 |
| Araújo, MGL; Fernandes, MJS; Franke, H; Gao, P; Illes, P; Khan, MT; Krügel, U; Liu, J; Rong, W; Rozmer, K; Tang, Y | 1 |
| Hirayama, Y; Koizumi, S | 1 |
| McLarnon, JG; Ryu, JK | 1 |
| Chen, MC; Liu, YP; Sun, SH; Tzeng, SF; Yang, CS | 1 |
| Chang, MY; Chen, YC; Chen, YH; Cheng, YC; Huang, YH; Hung, CC; Lu, JK; Tian, YC; Wu, MS; Yang, CW | 1 |
| Kelley, M; Li, L; Vessey, DA | 1 |
| Choi, HC; Choi, HK; Jo, SM; Kang, TC; Kim, JE; Ryu, HJ; Song, HK | 1 |
| Arbeloa, J; Gottlieb, M; Matute, C; Pérez-Samartín, A | 1 |
| Bashashati, M; Beck, PL; Gui, X; Gulbransen, BD; Hirota, SA; MacDonald, JA; Mawe, GM; McKay, DM; Muruve, DA; Roberts, JA; Sharkey, KA; Thompson, RJ | 1 |
| Austin, JS; Beggs, S; Costigan, M; Diatchenko, L; Dorfman, R; Gershon, E; Herbert, TA; John, SL; Jordan, J; Livneh, J; Maixner, W; Mogil, JS; Peltz, G; Ritchie, J; Salter, MW; Seltzer, Z; Slade, GD; Smith, SB; Sorge, RE; Tan, K; Tichauer, D; Trang, T; Vander Meulen, H; Woolf, CJ; Yarkoni-Abitbul, M; Zaykin, DV; Zheng, M | 1 |
| Greco, CR; Parvathenani, LK; Posmantur, R; Roberts, SB; Robertson, B; Tertyshnikova, S | 1 |
| Carroll, WA; Chu, KL; Donnelly-Roberts, DL; Fabiyi, AC; Faltynek, CR; Gauvin, DM; Gregg, RJ; Harris, RR; Honore, P; Jarvis, MF; Kort, ME; Marsh, K; McGaraughty, S; Namovic, MT; Nelson, DW; Shieh, CC; Wismer, CT; Zhang, XF; Zhu, CZ | 1 |
1 trial(s) available for 3'-o-(4-benzoyl)benzoyladenosine 5'-triphosphate and Disease Models, Animal
| Article | Year |
|---|---|
P2X7R/cryopyrin inflammasome axis inhibition reduces neuroinflammation after SAH.
Topics: Adenosine Triphosphate; Animals; Brain Edema; Carrier Proteins; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Encephalitis; Injections, Intraventricular; Lipopolysaccharides; Male; NLR Family, Pyrin Domain-Containing 3 Protein; Platelet Aggregation Inhibitors; Rats; Rats, Sprague-Dawley; Receptors, Cytoplasmic and Nuclear; Receptors, Purinergic P2X7; RNA, Small Interfering; Rosaniline Dyes; Signal Transduction; Subarachnoid Hemorrhage | 2013 |
25 other study(ies) available for 3'-o-(4-benzoyl)benzoyladenosine 5'-triphosphate and Disease Models, Animal
| Article | Year |
|---|---|
Contingent intramuscular boosting of P2XR7 axis improves motor function in transgenic ALS mice.
Topics: Adenosine Triphosphate; Amyotrophic Lateral Sclerosis; Animals; Axons; Biomarkers; Cell Differentiation; Cell Polarity; Cell Proliferation; Cell Survival; Denervation; Disease Models, Animal; Disease Progression; Female; Hindlimb; Humans; Inflammation; Injections, Intramuscular; Macrophages; Male; MAP Kinase Signaling System; Mice, Transgenic; Motor Activity; Motor Neurons; Muscle, Skeletal; Muscular Atrophy; Phenotype; Receptors, Purinergic P2X7; Satellite Cells, Skeletal Muscle; Schwann Cells; Sciatic Nerve | 2021 |
Saffron: Chemical Composition and Neuroprotective Activity.
Topics: Adenosine Triphosphate; Animals; Calcium; Carotenoids; Cell Line, Tumor; Cell Survival; Chromatography, High Pressure Liquid; Crocus; Disease Models, Animal; Flowers; HEK293 Cells; Humans; Light; Mice; Neurodegenerative Diseases; Neuroprotective Agents; Plant Extracts; Rats, Sprague-Dawley; Receptors, Purinergic P2X7; Retina; Retinal Degeneration; Vitamin A | 2020 |
Evidence that activation of P2X7R does not exacerbate neuronal death after optic nerve transection and focal cerebral ischemia in mice.
Topics: Adenosine Triphosphate; Animals; Animals, Newborn; Brain; Brain Edema; Brain Ischemia; Calcium-Binding Proteins; Cells, Cultured; Cerebral Cortex; Cytokines; Disease Models, Animal; DNA Fragmentation; Infusions, Intraventricular; Male; Mice; Mice, Inbred C57BL; Microfilament Proteins; Neurons; Optic Nerve Injuries; Platelet Aggregation Inhibitors; Receptors, Purinergic P2; Rosaniline Dyes | 2017 |
P2X7 receptor antagonist protects retinal ganglion cells by inhibiting microglial activation in a rat chronic ocular hypertension model.
Topics: Adenosine Triphosphate; Animals; Apoptosis; Caspase 1; Chronic Disease; Disease Models, Animal; Gene Expression; Microglia; Ocular Hypertension; Purinergic P2X Receptor Antagonists; Rats; Receptors, Purinergic P2X7; Retina; Retinal Ganglion Cells | 2018 |
Zidovudine ameliorates pathology in the mouse model of Duchenne muscular dystrophy via P2RX7 purinoceptor antagonism.
Topics: Adenosine Triphosphate; Animals; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antimetabolites; Calcium; Cells, Cultured; Collagen Type IV; Creatine Kinase; Disease Models, Animal; Male; Mice; Mice, Inbred mdx; Mice, Transgenic; Models, Molecular; Muscle Strength; Muscles; Muscular Dystrophy, Duchenne; Myoblasts; Receptors, Purinergic P2X7; Zidovudine | 2018 |
The interaction between P2X7Rs and T-type calcium ion channels in penicillin-induced epileptiform activity.
Topics: Adenosine Triphosphate; Animals; Antioxidants; Benzimidazoles; Brain Stem; Calcium Channels, T-Type; Cerebellum; Cerebrum; Cyclopropanes; Disease Models, Animal; Epilepsy; Naphthalenes; Penicillins; Purinergic P2X Receptor Agonists; Purinergic P2X Receptor Antagonists; Pyridines; Rats; Rats, Wistar; Receptors, Purinergic P2X7; Tetrazoles | 2019 |
NFATc3 promotes Ca(2+) -dependent MMP3 expression in astroglial cells.
Topics: Adenosine Triphosphate; Animals; Animals, Newborn; Astrocytes; Brain; Calcium; Cerebral Cortex; Disease Models, Animal; Enzyme Inhibitors; Flow Cytometry; Gene Expression Regulation; Matrix Metalloproteinase 3; Mice; Mice, Inbred C57BL; NFATC Transcription Factors; Phorbol 12,13-Dibutyrate; Signal Transduction; Time Factors; Wounds and Injuries | 2013 |
Pharmacological characterization of a novel centrally permeable P2X7 receptor antagonist: JNJ-47965567.
Topics: Adenosine Triphosphate; Analgesics; Animals; Antidepressive Agents; Antimanic Agents; Behavior, Animal; Binding, Competitive; Bipolar Disorder; Blood-Brain Barrier; Brain; Calcium Signaling; Capillary Permeability; Cell Line; Depression; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Humans; Interleukin-1beta; Macaca; Male; Mice; Mice, Inbred C57BL; Neuralgia; Niacinamide; Piperazines; Protein Binding; Purinergic P2X Receptor Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P2X7; Time Factors; Transfection | 2013 |
P2X7 receptor inhibition increases CNTF in the subventricular zone, but not neurogenesis or neuroprotection after stroke in adult mice.
Topics: Adenosine Triphosphate; Affinity Labels; Animals; Ciliary Neurotrophic Factor; Cytokines; Disease Models, Animal; Indicators and Reagents; Infarction, Middle Cerebral Artery; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Neurogenesis; Neuroprotective Agents; Purinergic P2X Receptor Antagonists; Receptors, Purinergic P2X7; Rosaniline Dyes; Stroke | 2013 |
Peripheral P2X7 receptor-induced mechanical hyperalgesia is mediated by bradykinin.
Topics: Adenosine Triphosphate; Animals; Bradykinin; Chemokine CXCL1; Cytokines; Disease Models, Animal; Hindlimb; Hyperalgesia; Interleukin-1beta; Male; Neuroimmunomodulation; Rats, Wistar; Receptors, Purinergic P2X1; Receptors, Purinergic P2X2; Receptors, Purinergic P2X3; Receptors, Purinergic P2X7; Subcutaneous Tissue; Touch | 2014 |
Involvement of the P2X7 purinergic receptor in colonic motor dysfunction associated with bowel inflammation in rats.
Topics: Adenosine Triphosphate; Animals; Benzenesulfonates; Colitis; Disease Models, Animal; Guanidines; Male; Muscle, Smooth; Neurons; Purinergic P2X Receptor Agonists; Purinergic P2X Receptor Antagonists; Quinolines; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P2X7 | 2014 |
Effects of naringin on learning and memory dysfunction induced by gp120 in rats.
Topics: Adenosine Triphosphate; Animals; Cells, Cultured; Cerebral Cortex; Disease Models, Animal; Flavanones; Gene Expression Regulation; Hippocampus; HIV Envelope Protein gp120; Learning Disabilities; Maze Learning; Memory Disorders; Microglia; Platelet Aggregation Inhibitors; Purinergic P2X Receptor Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P2X7 | 2016 |
Transient P2X7 Receptor Antagonism Produces Lasting Reductions in Spontaneous Seizures and Gliosis in Experimental Temporal Lobe Epilepsy.
Topics: Adenosine Triphosphate; Adolescent; Adult; Animals; Brain; Calcium-Binding Proteins; Disease Models, Animal; Epilepsy, Temporal Lobe; Gene Expression Regulation; Gliosis; Green Fluorescent Proteins; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microfilament Proteins; Middle Aged; Nerve Tissue Proteins; Niacinamide; Piperazines; Platelet Aggregation Inhibitors; Purinergic P2X Receptor Antagonists; Receptors, Purinergic P2X7; Seizures; Up-Regulation; Young Adult | 2016 |
Pilocarpine-Induced Status Epilepticus Increases the Sensitivity of P2X7 and P2Y1 Receptors to Nucleotides at Neural Progenitor Cells of the Juvenile Rodent Hippocampus.
Topics: Adamantane; Adenosine Triphosphate; Aminoquinolines; Animals; Disease Models, Animal; Excitatory Amino Acid Agents; Female; Gene Expression Regulation; Green Fluorescent Proteins; Hippocampus; Male; Membrane Potentials; Mice; Mice, Transgenic; Muscarinic Agonists; Neural Stem Cells; Nucleotides; Pilocarpine; Purinergic P2X Receptor Antagonists; Receptors, Purinergic P2X7; Receptors, Purinergic P2Y1; Status Epilepticus | 2017 |
Hypoxia-independent mechanisms of HIF-1α expression in astrocytes after ischemic preconditioning.
Topics: Adenosine Triphosphate; Animals; Astrocytes; Brain; Cells, Cultured; Disease Models, Animal; Functional Laterality; Gene Expression Regulation; Glial Fibrillary Acidic Protein; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Infarction, Middle Cerebral Artery; Ischemic Preconditioning; Mice; Mice, Inbred C57BL; Mice, Knockout; Neurons; Phosphopyruvate Hydratase; Platelet Aggregation Inhibitors; Receptors, Purinergic P2X7 | 2017 |
Block of purinergic P2X(7) receptor is neuroprotective in an animal model of Alzheimer's disease.
Topics: Adenosine Triphosphate; Alzheimer Disease; Amyloid beta-Peptides; Animals; Blood-Brain Barrier; Disease Models, Animal; Gliosis; Hippocampus; Immunohistochemistry; Male; Neurons; Neuroprotective Agents; Peptide Fragments; Platelet Aggregation Inhibitors; Purinergic P2 Receptor Agonists; Purinergic P2 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P2 | 2008 |
Ca(2+)-dependent reduction of glutamate aspartate transporter GLAST expression in astrocytes by P2X(7) receptor-mediated phosphoinositide 3-kinase signaling.
Topics: Adenosine Triphosphate; Animals; Animals, Newborn; Aspartic Acid; Astrocytes; Benzoxazoles; Calcium; Cells, Cultured; Disease Models, Animal; Enzyme Inhibitors; Excitatory Amino Acid Transporter 1; Female; Gene Expression Regulation; Glutamic Acid; Humans; Injections, Spinal; Neurons; Phosphatidylinositol 3-Kinases; Platelet Aggregation Inhibitors; Purinergic P2 Receptor Agonists; Purinergic P2 Receptor Antagonists; Pyridoxal Phosphate; Quinolinium Compounds; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P2; Receptors, Purinergic P2X7; RNA, Messenger; RNA, Small Interfering; Signal Transduction; Spinal Cord Injuries; Transfection | 2010 |
Inhibition of the P2X7 receptor reduces cystogenesis in PKD.
Topics: Adenosine Triphosphate; Animals; Cell Proliferation; Cilia; Disease Models, Animal; Epithelial Cells; Extracellular Signal-Regulated MAP Kinases; Gene Knockdown Techniques; Humans; Interleukin-1beta; Kidney Tubules, Proximal; MAP Kinase Signaling System; Phenotype; Polycystic Kidney, Autosomal Dominant; Purinergic P2X Receptor Agonists; Purinergic P2X Receptor Antagonists; Pyridines; Receptors, Purinergic P2X7; RNA, Messenger; Tetrazoles; Zebrafish | 2011 |
P2X7 receptor agonists pre- and postcondition the heart against ischemia-reperfusion injury by opening pannexin-1/P2X₇ channels.
Topics: Adenosine Triphosphate; Analysis of Variance; Animals; Cardiotonic Agents; Connexins; Disease Models, Animal; Drug Administration Schedule; Lysophospholipids; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Nerve Tissue Proteins; Perfusion; Purinergic P2X Receptor Agonists; Purinergic P2X Receptor Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Lysosphingolipid; Receptors, Purinergic P2X7; Sphingosine; Time Factors; Ventricular Function, Left; Ventricular Pressure | 2011 |
The roles of P2X7 receptor in regional-specific microglial responses in the rat brain following status epilepticus.
Topics: Adenosine Triphosphate; Animals; Brain; Disease Models, Animal; Gene Expression Regulation; Male; Microglia; Muscarinic Agonists; Pilocarpine; Purinergic P2X Receptor Agonists; Purinergic P2X Receptor Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P2X7; Status Epilepticus; Time Factors | 2012 |
P2X7 receptor blockade prevents ATP excitotoxicity in neurons and reduces brain damage after ischemia.
Topics: Adenosine Triphosphate; Analysis of Variance; Animals; Brain Injuries; Calcium; Cells, Cultured; Cerebral Cortex; Disease Models, Animal; Dose-Response Relationship, Drug; Embryo, Mammalian; Excitatory Amino Acid Agonists; Fluoresceins; Glucose; Hypoxia; In Vitro Techniques; Infarction, Middle Cerebral Artery; Membrane Potentials; N-Methylaspartate; Neurologic Examination; Neurons; Organic Chemicals; Patch-Clamp Techniques; Phosphopyruvate Hydratase; Purinergic P2X Receptor Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P2X7; Rosaniline Dyes; Tetrazolium Salts | 2012 |
Activation of neuronal P2X7 receptor-pannexin-1 mediates death of enteric neurons during colitis.
Topics: Adenosine Triphosphate; Analysis of Variance; Animals; Apoptosis Regulatory Proteins; Calcium; CARD Signaling Adaptor Proteins; Carrier Proteins; Caspases; Cell Death; Colitis; Connexins; Cytoskeletal Proteins; Dinitrofluorobenzene; Disease Models, Animal; Dose-Response Relationship, Drug; Estrenes; Gastrointestinal Motility; Gene Expression Regulation; Glial Fibrillary Acidic Protein; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myenteric Plexus; Nerve Tissue Proteins; Neurons; Nitric Oxide Synthase Type I; NLR Family, Pyrin Domain-Containing 3 Protein; Phosphodiesterase Inhibitors; Purinergic P2X Receptor Agonists; Pyrrolidinones; Receptors, Purinergic P2X7; Signal Transduction; Time Factors | 2012 |
Genetically determined P2X7 receptor pore formation regulates variability in chronic pain sensitivity.
Topics: Adenosine Triphosphate; Animals; Benzoxazoles; Calcium; Carbenoxolone; Cells, Cultured; Chronic Pain; Cohort Studies; Connexins; Disease Models, Animal; Enzyme Inhibitors; Female; Genetic Linkage; Genome-Wide Association Study; Genotype; Histidine; Humans; Hyperalgesia; Macrophages; Male; Mastectomy; Mice; Mice, Inbred Strains; Mutation; Nerve Tissue Proteins; Osteoarthritis; Pain Measurement; Pain Threshold; Peptides; Polymorphism, Single Nucleotide; Quinolinium Compounds; Receptors, Purinergic P2X7; Retrospective Studies; Species Specificity; Time Factors; Transfection | 2012 |
P2X7 mediates superoxide production in primary microglia and is up-regulated in a transgenic mouse model of Alzheimer's disease.
Topics: Adenosine Triphosphate; Alzheimer Disease; Animals; Animals, Newborn; Calcium; Cerebral Cortex; Chromones; Disease Models, Animal; Embryo, Mammalian; Enzyme Inhibitors; Female; Humans; Kinetics; MAP Kinase Signaling System; Mice; Mice, Transgenic; Microglia; Morpholines; NADPH Oxidases; Neutrophils; Phosphoinositide-3 Kinase Inhibitors; Pregnancy; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P2; Receptors, Purinergic P2X7; Superoxides; Up-Regulation | 2003 |
P2X7-related modulation of pathological nociception in rats.
Topics: Action Potentials; Adenosine Triphosphate; Analgesics; Animals; Astrocytoma; Behavior, Animal; Cell Line, Tumor; Disease Models, Animal; Dose-Response Relationship, Drug; Ganglia, Spinal; Humans; Interleukin-1beta; Male; Mice; Mice, Inbred BALB C; Neurons; Pain Measurement; Purinergic P2 Receptor Agonists; Purinergic P2 Receptor Antagonists; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P2; Receptors, Purinergic P2X7; Sciatica; Tetrazoles; Time Factors | 2007 |